Literature DB >> 25538215

Chronic meningitis with intracranial hypertension and bilateral neuroretinitis following Mycoplasma pneumoniae infection.

Konstantinos Karampatsas1, Himanshu Patel2, Sheikh N Basheer3, Andrew J Prendergast4.   

Abstract

A previously well 12-year-old boy presented with a 2-week history of headache, nausea, vomiting and left-sided weakness. He subsequently developed meningism, right abducens nerve palsy, persistent papilloedema and reduced visual acuity in association with a bilateral macular star, consistent with neuroretinitis. Cerebrospinal fluid (CSF) examination indicated chronic meningitis and serological testing confirmed recent Mycoplasma pneumoniae infection, although PCR in CSF was negative. He was treated for aseptic meningitis with ceftriaxone, aciclovir, azithromycin and acetazolamide for intracranial hypertension, with gradual improvement in clinical condition and visual acuity over several weeks. This is the first report of M. pneumoniae chronic meningitis further complicated with bilateral neuroretinitis and intracranial hypertension. Evidence of central nervous system inflammation in the absence of direct infection suggests an immune-mediated pathophysiology. Although the use of macrolides with antibiotic and immunomodulatory activity might be beneficial, it was not possible to ascertain whether it influenced clinical recovery in this case. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25538215      PMCID: PMC4275690          DOI: 10.1136/bcr-2014-207041

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Pediatric encephalitis: what is the role of Mycoplasma pneumoniae?

Authors:  Laura J Christie; Somayeh Honarmand; Deborah F Talkington; Shilpa S Gavali; Chris Preas; Chao-Yang Pan; Shigeo Yagi; Carol A Glaser
Journal:  Pediatrics       Date:  2007-08       Impact factor: 7.124

2.  Meningitis associated with bilateral optic papillitis following Mycoplasma pneumoniae infection.

Authors:  Zhen-Ni Guo; Hong-Liang Zhang; Jing Bai; Jiang Wu; Yi Yang
Journal:  Neurol Sci       Date:  2011-07-06       Impact factor: 3.307

Review 3.  Central nervous system manifestations of Mycoplasma pneumoniae infections.

Authors:  S Tsiodras; I Kelesidis; T Kelesidis; E Stamboulis; H Giamarellou
Journal:  J Infect       Date:  2005-09-19       Impact factor: 6.072

Review 4.  Mycoplasma pneumoniae and central nervous system complications: a review.

Authors:  Randeep Guleria; Nazima Nisar; Tirlok Chand Chawla; Nihar Ranjan Biswas
Journal:  J Lab Clin Med       Date:  2005-08

Review 5.  Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection.

Authors:  Mitsuo Narita
Journal:  Pediatr Neurol       Date:  2009-09       Impact factor: 3.372

6.  Acute childhood encephalitis and Mycoplasma pneumoniae.

Authors:  A Bitnun; E L Ford-Jones; M Petric; D MacGregor; H Heurter; S Nelson; G Johnson; S Richardson
Journal:  Clin Infect Dis       Date:  2001-05-21       Impact factor: 9.079

7.  Investigating chronic meningitis.

Authors:  N Syed; A Saxena; L Hartley
Journal:  Arch Dis Child Educ Pract Ed       Date:  2009-10       Impact factor: 1.309

Review 8.  Bilateral optic papillitis following mycoplasma pneumoniae pneumonia.

Authors:  E Milla; L Zografos; B Piguet
Journal:  Ophthalmologica       Date:  1998       Impact factor: 3.250

9.  Intracranial hypertension in a boy with Mycoplasma pneumoniae infection: the first report.

Authors:  Sari Masutani; Rumiko Takayama; Takeshi Tsugawa; Koki Nikaido; Toshiaki Doi; Hiroyuki Tsutsumi
Journal:  Scand J Infect Dis       Date:  2004

Review 10.  Mycoplasma meningitis resulting in increased production of cerebrospinal fluid: case report and review of the literature.

Authors:  David F Bauer; R Shane Tubbs; Leslie Acakpo-Satchivi
Journal:  Childs Nerv Syst       Date:  2008-02-28       Impact factor: 1.475

View more
  2 in total

Review 1.  [Spinal cord ischemia].

Authors:  K Alektoroff; M Kettner; P Papanagiotou
Journal:  Radiologe       Date:  2021-02-13       Impact factor: 0.635

Review 2.  [Clinical implications of the genus Mycoplasma].

Authors:  D Gómez Rufo; E García Sánchez; J E García Sánchez; M García Moro
Journal:  Rev Esp Quimioter       Date:  2021-03-18       Impact factor: 1.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.